No takes yet. Share an insight, caveat, or question.
Bioinformatic platform development demonstrates robust immune cell infiltration profiling across diverse cancer types, highlighting actionable tumor-immune interactions.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: